health news arrowHome >> Genetic Research >> Gene Discovery May Aid Diagnosis of Prostate Cancer Tue, 24 Nov 2009 GMT 
health news
  NEWS YOU CAN TRUST

Search Health News 
Browser Preferences
 Add to Favorites

Main Menu
 Home
 - - - - - Hot Topics - - - - -
 Bird Flu
 Drug Safety
 Stem Cell Research
 - - - - - - - - - - - - - - - - -
 Alternative Medicine
 Children's Health
 Diet & Nutrition
 Disabilities
 *Diseases & Conditions
 Drugs & Herbs
 Environmental Health
 Fitness & Exercise
 Genetic Research
 Health Insurance
 Medical Ethics
 Men's Health
 *Mental Illness
 Pain
 Parenting
 Public Health & Safety
 Senior Care
 *Sexual Health
 Women's Health
 World Health
 - - - - - - - - - - - - - - - -
 Web Links
 Contact Us: info@dailynewscentral.com

XML News Feeds


 

HEALTH NEWS

Gene Discovery May Aid Diagnosis of Prostate Cancer

PDF  Print  E-mail
 08 May, 2006  03:26 GMT

gene variant prostate cancer
A newly discovered gene variant -- carried by about 13 percent of men of European ancestry -- raises the risk of getting prostate cancer by 60 percent, compared with men who are not carriers.
Scientists in Iceland report a breakthrough that may lead to a diagnostic test to help identify prime candidates for aggressive treatment for prostate cancer.

The discovery a variant gene associated with prostate cancer -- by the gene-finding company DeCode Genetics -- may also help explain why blacks have a greater incidence of the disease, The New York Times reported.

Detection of underlying genes implicated in prostate cancer is difficult because each gene seems to have only a small effect on the risk of getting the disease, the Times said.

Several candidate genes have been identified in one family or population, but researchers have not had success in trying to replicate such findings in other populations.

Statistically Convincing

The new variant, described online in the journal Nature Genetics, was first found in Icelandic men, said the Times, and then detected in Sweden and in two populations in the United States.

David Altshuler, a medical geneticist at the Broad Institute in Cambridge, Mass., said the result was statistically convincing.

The variant -- carried by about 13 percent of men of European ancestry -- raises the risk of getting prostate cancer by 60 percent, compared with men who are not carriers, said the DeCode researchers. It also accounts for about 8 percent of all cases.




Related Articles
Hot Peppers Have Chilling Effect on Prostate Cancer Cells (16 Mar 2006)
Gene Variants Linked to Nicotine Addiction (24 Nov 2004)
Report: Prostate Cancer Treatment Requires Team Approach (23 Sep 2004)
Sun Exposure Lessens Prostate Cancer Risk (15 Jun 2005)
Gene for Slow Caffeine Metabolism Linked to Heart Attacks (8 Mar 2006)
Obesity Hampers Accuracy of Prostate Cancer Tests (24 Jan 2005)
 
Sponsored Text Links
InsureMe.com: Click here to get a free health insurance quote.
SkinStore.com: StriVectin-SD
Hydroderm: Lose wrinkles with Hydroderm
Hydroderm: Body Shape - Proven to be safe and effective - Free Trial!
SkinStore.com: Strivectin SD 6oz Best Price Offer